CLONU-0.5 MD

CLONU-0.5 MD contains Clonazepam 0.5 mg in a mouth-dissolving tablet formulation. This pharmaceutical product is presented in a convenient oral dosage form, with the brand name and strength clearly identified on the product packaging for accurate product recognition and catalogue management.

Clonazepam belongs to the benzodiazepine class of medicines. CLONU-0.5 MD is listed as a Clonazepam formulation within Suprimeda’s pharmaceutical product portfolio. Its mouth-dissolving dosage form distinguishes it from conventional tablets, while the labelled strength of 0.5 mg supports clear identification by healthcare professionals, pharmacists and institutional procurement teams.

For pharmaceutical catalogue purposes, CLONU-0.5 MD is identified by its active ingredient, strength, dosage form and marketed brand name. The product is presented in a carton marked with a pack configuration of 4 × 5 × 10 tablets. These details help hospitals, pharmacies and authorised pharmaceutical distributors identify the product accurately when reviewing product listings and procurement requirements.